Federal Project Grant Award Summary

The University of California, San Diego received a $1.6M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026, through June 30, 2029. The award supports research investigating nonneuronal acetylcholine receptor action in triple-negative breast cancer, a focus area aligned with the DHA's emphasis on transforming healthcare for service members and the American public through innovative biomedical research solutions. As a leading research-intensive academic medical center, UCSD will deliver hypothesis-driven research and translational research activities addressing this critical oncology challenge.

The project represents a competitive award under the DHA's two-tier review process, which evaluates applications for both technical merit and military relevance. The three-year performance period and funding level are consistent with typical awards in the Military Medical Research and Development program, which generally ranges from $100,000 to $20M depending on project scope and funding priorities. UCSD's institutional expertise in advanced biomedical research, combined with its established track record of managing federally funded cancer research initiatives, positions the institution to deliver meaningful scientific contributions through this investigation.